A
Price
$124.39
Change
-$1.55 (-1.23%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
35.7B
68 days until earnings call
ALC
Price
$74.97
Change
-$0.23 (-0.31%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
37.71B
49 days until earnings call
Interact to see
Advertisement

A vs ALC

Header iconA vs ALC Comparison
Open Charts A vs ALCBanner chart's image
Agilent Technologies
Price$124.39
Change-$1.55 (-1.23%)
Volume$5.92K
Capitalization35.7B
Alcon
Price$74.97
Change-$0.23 (-0.31%)
Volume$37.22K
Capitalization37.71B
A vs ALC Comparison Chart in %
Loading...
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ALC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
A vs. ALC commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a Hold and ALC is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (A: $125.94 vs. ALC: $75.20)
Brand notoriety: A and ALC are both not notable
A represents the Medical Specialties, while ALC is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: A: 79% vs. ALC: 142%
Market capitalization -- A: $35.7B vs. ALC: $37.71B
A [@Medical Specialties] is valued at $35.7B. ALC’s [@Pharmaceuticals: Other] market capitalization is $37.71B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $160.51B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.62B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 0 FA rating(s) are green whileALC’s FA Score has 0 green FA rating(s).

  • A’s FA Score: 0 green, 5 red.
  • ALC’s FA Score: 0 green, 5 red.
According to our system of comparison, A is a better buy in the long-term than ALC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 4 TA indicator(s) are bullish while ALC’s TA Score has 4 bullish TA indicator(s).

  • A’s TA Score: 4 bullish, 6 bearish.
  • ALC’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ALC is a better buy in the short-term than A.

Price Growth

A (@Medical Specialties) experienced а -0.98% price change this week, while ALC (@Pharmaceuticals: Other) price change was -3.14% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.98%. For the same industry, the average monthly price growth was +3.76%, and the average quarterly price growth was +26.54%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.26%. For the same industry, the average monthly price growth was -1.79%, and the average quarterly price growth was +9.31%.

Reported Earning Dates

A is expected to report earnings on Dec 01, 2025.

ALC is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Medical Specialties (+0.98% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (-0.26% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALC($37.7B) has a higher market cap than A($35.7B). ALC has higher P/E ratio than A: ALC (34.81) vs A (29.43). A YTD gains are higher at: -5.856 vs. ALC (-11.415). ALC has higher annual earnings (EBITDA): 2.74B vs. A (1.8B). A has more cash in the bank: 1.54B vs. ALC (1.41B). A has less debt than ALC: A (3.41B) vs ALC (5.25B). ALC has higher revenues than A: ALC (10B) vs A (6.79B).
AALCA / ALC
Capitalization35.7B37.7B95%
EBITDA1.8B2.74B65%
Gain YTD-5.856-11.41551%
P/E Ratio29.4334.8185%
Revenue6.79B10B68%
Total Cash1.54B1.41B109%
Total Debt3.41B5.25B65%
FUNDAMENTALS RATINGS
A vs ALC: Fundamental Ratings
A
ALC
OUTLOOK RATING
1..100
7668
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
70
Overvalued
PROFIT vs RISK RATING
1..100
7166
SMR RATING
1..100
4585
PRICE GROWTH RATING
1..100
5382
P/E GROWTH RATING
1..100
4575
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

A's Valuation (53) in the Biotechnology industry is in the same range as ALC (70) in the Hospital Or Nursing Management industry. This means that A’s stock grew similarly to ALC’s over the last 12 months.

ALC's Profit vs Risk Rating (66) in the Hospital Or Nursing Management industry is in the same range as A (71) in the Biotechnology industry. This means that ALC’s stock grew similarly to A’s over the last 12 months.

A's SMR Rating (45) in the Biotechnology industry is somewhat better than the same rating for ALC (85) in the Hospital Or Nursing Management industry. This means that A’s stock grew somewhat faster than ALC’s over the last 12 months.

A's Price Growth Rating (53) in the Biotechnology industry is in the same range as ALC (82) in the Hospital Or Nursing Management industry. This means that A’s stock grew similarly to ALC’s over the last 12 months.

A's P/E Growth Rating (45) in the Biotechnology industry is in the same range as ALC (75) in the Hospital Or Nursing Management industry. This means that A’s stock grew similarly to ALC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AALC
RSI
ODDS (%)
Bearish Trend 2 days ago
61%
Bullish Trend 2 days ago
49%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
56%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
41%
MACD
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
49%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
50%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
46%
Advances
ODDS (%)
Bullish Trend 9 days ago
62%
Bullish Trend 20 days ago
60%
Declines
ODDS (%)
Bearish Trend 16 days ago
60%
Bearish Trend 10 days ago
57%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
53%
Bullish Trend 2 days ago
47%
Aroon
ODDS (%)
Bullish Trend 2 days ago
61%
Bearish Trend 2 days ago
49%
View a ticker or compare two or three
Interact to see
Advertisement
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ALC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MBND27.43N/A
N/A
SPDR® Nuveen Municipal Bond ETF
AVSE63.83-0.16
-0.24%
Avantis Responsible Emerging Mkts Eq ETF
CGMM28.51-0.07
-0.24%
Capital Group U.S. Small & Mid Cap ETF
HFRO6.77-0.02
-0.32%
Highland Opportunities and Income Fund
QLD136.44-1.87
-1.35%
ProShares Ultra QQQ

A and

Correlation & Price change

A.I.dvisor indicates that over the last year, A has been closely correlated with MTD. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if A jumps, then MTD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To A
1D Price
Change %
A100%
-0.31%
MTD - A
85%
Closely correlated
-0.08%
TMO - A
79%
Closely correlated
-1.10%
WAT - A
79%
Closely correlated
-1.08%
RVTY - A
78%
Closely correlated
-0.65%
DHR - A
75%
Closely correlated
-0.39%
More

ALC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALC has been loosely correlated with SYK. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ALC jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALC
1D Price
Change %
ALC100%
-3.07%
SYK - ALC
55%
Loosely correlated
-1.24%
A - ALC
54%
Loosely correlated
-0.31%
DHR - ALC
54%
Loosely correlated
-0.39%
TMO - ALC
53%
Loosely correlated
-1.10%
COO - ALC
51%
Loosely correlated
-0.74%
More